Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer. Discover why early detection makes treatment more effective and far less ...
A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a ...
Five-year survival rates are among the lowest of all cancers, at about 25%. But when caught early enough – through annual CT ...
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...
A new long-term study published in the New England Journal of Medicine followed 160,000 men for over two decades to examine ...
An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...
Recognising these subtle body changes can lead to an earlier diagnosis, when treatment is more likely to be successful ...
Free prostate cancer screening for men 40+ on Sat., March 21, 10 a.m.–2 p.m. at Pike County Health Department in Troy; no ...